Trend Tracker: HMO Innovations, Social Commerce Strategies, Sports Nutrition

Why It Matters

These regulatory and distribution shifts reshape product pipelines, pricing dynamics, and channel strategies, forcing global nutrition players to adapt quickly or risk losing market share.

Key Takeaways

• HMO regulatory approvals enable broader, cheaper infant‑formula options in APAC
• Douyin becomes primary e‑commerce platform for Chinese vitamin and supplement brands
• India’s sports‑nutrition growth is offset by misinformation and price‑sensitivity challenges
• Soy protein heart‑health claim unlocks new plant‑based product formats in ANZ

Pulse Analysis

The wave of regulatory clearances for human milk oligosaccharides (HMOs) is redefining infant nutrition in the Asia‑Pacific region. As the third‑most abundant solid in breast milk, HMOs now serve as a cornerstone for formula innovation, allowing manufacturers to mimic key bioactive functions while driving down costs through scale. Industry leaders such as H&H Group’s China division are betting on broader HMO inclusion to differentiate products and meet rising parental demand for premium yet affordable nutrition.

In parallel, Chinese supplement brands are re‑routing their go‑to‑market strategies toward Douyin, the country’s dominant short‑video platform. Haleon plans to amplify content output and enlist more key‑opinion leaders, while BYHEALTH is pivoting from traditional pharmacy channels to cross‑border e‑commerce and Douyin‑driven sales. This digital thrust reflects a broader consumer shift toward socially curated shopping experiences, compelling brands to invest heavily in video storytelling, live‑stream promotions, and data‑rich influencer partnerships to capture market share.

Beyond infant formula and e‑commerce, ingredient‑level approvals are unlocking new product categories. IFF’s self‑substantiated heart‑health claim for isolated soy protein in Australia and New Zealand paves the way for fortified plant‑based milks, RTD functional drinks, and protein bars, aligning with growing consumer focus on cardiovascular wellness. Meanwhile, fish‑oil players like WHC Labs and Swisse are mitigating supply‑chain volatility by building inventory buffers and forecasting raw‑material needs up to a year ahead. In India, the sports‑nutrition segment offers “immense opportunity,” yet brands must navigate misinformation, price sensitivity, and quality consistency to fully capitalize on the market’s rapid expansion.